These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 8296609

  • 1. The nosology of Wegener's granulomatosis utilizing the elk format augmented by c-ANCA.
    DeRemee RA.
    Adv Exp Med Biol; 1993; 336():209-15. PubMed ID: 8296609
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of Wegener's granulomatosis with intravenous immunoglobulin.
    Richter C, Schnabel A, Csernok E, Reinhold-Keller E, Gross WL.
    Adv Exp Med Biol; 1993; 336():487-9. PubMed ID: 8296662
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis.
    Soukiasian SH, Foster CS, Niles JL, Raizman MB.
    Ophthalmology; 1992 Jan; 99(1):125-32. PubMed ID: 1741124
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis.
    Rao JK, Allen NB, Feussner JR, Weinberger M.
    Lancet; 1995 Oct 07; 346(8980):926-31. PubMed ID: 7564726
    [Abstract] [Full Text] [Related]

  • 8. [Significance of anti-neutrophil cytoplasmic autoantibodies in the diagnosis of Wegener's granulomatosis].
    Zielonka TM, Samoliński B, Tchórzewska H, Chorzelski T, Droszcz W.
    Pol Arch Med Wewn; 1991 Aug 07; 86(2):113-6. PubMed ID: 1775389
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The hearing loss in Wegener's granulomatosis: relationship between hearing loss and serum ANCA.
    Okamura H, Ohtani I, Anzai T.
    Auris Nasus Larynx; 1992 Aug 07; 19(1):1-6. PubMed ID: 1514941
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Wegener's granulomatosis & ANCA-associated diseases: the story continues. Introduction.
    Kekow J, Gross WL.
    Adv Exp Med Biol; 1993 Aug 07; 336():v-ix. PubMed ID: 8296593
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ANCA-associated vasculitides. Immunological and clinical aspects. Proceedings of the 4th International Workshop on ANCA and the 2nd International Colloquium on Wegener's Granulomatosis and Vasculitic Disorders. May 28-30, 1992, Lübeck, Germany.
    Adv Exp Med Biol; 1993 Aug 07; 336():1-549. PubMed ID: 8296595
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. c-ANCA as a marker of Wegener's disease.
    Bosch X, Urbano-Márquez A.
    Lancet; 1996 Jan 13; 347(8994):117; author reply 118. PubMed ID: 8538309
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
    van de Wiel BA, Dolman KM, van der Meer-Gerritsen CH, Hack CE, von dem Borne AE, Goldschmeding R.
    Clin Exp Immunol; 1992 Dec 13; 90(3):409-14. PubMed ID: 1458677
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.